Oral Insulin Breakthroughs In Development INTRODUCTION Diabetes is a chronic metabolic disorder primarily classified into two types: type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). T1DM, an autoimmune disease often diagnosed in adolescence, is marked by the body's inability to produce insulin. In contrast, T2DM, which constitutes the majority
Tag: prescription medication
Dental Extraction Prophylaxis Treatment With Antibiotics Is Controversial
Dental Extraction Prophylaxis Treatment With Antibiotics Is Controversial Overview This study aimed to assess the relationship between antibiotic prophylaxis and adverse outcomes following dental extractions within the Veterans Affairs Healthcare System. Researchers conducted a retrospective cohort analysis of patients who underwent tooth extractions from 2015 to 2019, focusing on antibiotic use and
Oxymetazoline Successful Therapy To Improve Droopy Eye Appearance
Oxymetazoline Successful Therapy To Improve Droopy Eye Appearance Overview Oxymetazoline hydrochloride has demonstrated effectiveness in several studies for treating acquired blepharoptosis and improving the aesthetic appearance of the upper eyelid. This study systematically reviewed existing literature on the topical use of oxymetazoline for the treatment of acquired blepharoptosis. A comprehensive review was
Attacking Heart Failure Inflammation With Prednisone
Attacking Heart Failure Inflammation With Prednisone Overview Burst steroid therapy, commonly used in acute respiratory diseases, may provide benefits for patients with acute heart failure (AHF), where inflammation plays a key role in adverse outcomes. The CORTAHF trial aimed to evaluate whether a short course of steroid therapy could reduce inflammation and
Stroke Victim Compliance With Prescription Medication
Stroke Victim Compliance With Prescription Medication Overview Adherence to secondary prevention medications following an ischemic stroke or transient ischemic attack is crucial for reducing recurrence risk. This study assessed medication adherence over a three-year period post-stroke using prescription and dispensing data, and aimed to identify factors influencing suboptimal adherence. Conducted as a multicenter,
Antipsychotic Injectable Medications Deplete Neurotrophic Factor In Schizophrenia Patients
Antipsychotic Injectable Medications Deplete Neurotrophic Factor In Schizophrenia Patients Overview Schizophrenia (SCZ) and schizoaffective disorder (SAD) are severe psychiatric conditions influenced by both genetic and environmental factors. Serum brain-derived neurotrophic factor (BDNF) has been identified as a potential biomarker for these disorders, though its temporal changes remain unclear. This study analyzes data
The Fenofibrate Role In The Fight For Kidney Function Preservation
The Fenofibrate Role In The Fight For Kidney Function Preservation Chronic kidney disease (CKD) and end-stage renal disease (ESRD) are increasingly significant global health concerns, with CKD now affecting an estimated 9.1% of the world's population—a 29.3% increase since 1990. This rise has severe implications, contributing to 1.2 million deaths annually
Valoctocogene Roxaparvovec Gene Therapy Success Detailed For Hemophilia A Patients
Valoctocogene Roxaparvovec Gene Therapy Success Detailed For Hemophilia A Patients Overview Valoctocogene roxaparvovec is a gene therapy utilizing an adeno-associated virus serotype 5 (AAV5) vector, approved for treating severe hemophilia A (HA). The purpose of this summary is to present the safety and efficacy outcomes observed seven years post-dosing in a phase
Efgartigimod Provides Genuine Benefit For Myasthenia Gravis Disease
Efgartigimod Provides Genuine Benefit For Myasthenia Gravis Disease Overview Efgartigimod, a neonatal Fc receptor inhibitor, has recently received approval for the treatment of myasthenia gravis (MG). This retrospective cohort study systematically evaluated the short- and long-term efficacy of efgartigimod in patients with refractory MG. Sixteen patients with autoimmune acetylcholine receptor MG, who
Semaglutide Use Shows Bonus Benefit Of Osteoarthritis Risk Reduction
Semaglutide Use Shows Bonus Benefit Of Osteoarthritis Risk Reduction Overview Osteoarthritis (OA) is a widespread degenerative joint condition. While the influence of obesity on OA is well-established, the effect of semaglutide on OA remains less understood. The objective was to evaluate the effect of semaglutide on the risk of OA among patients with
